FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024097777> ?p ?o ?g. }

• W2024097777 endingPage "550" @default.
• W2024097777 startingPage "537" @default.
• W2024097777 abstract "To evaluate the efficacy and safety of aripiprazole treatment for psychotic symptoms associated with Alzheimer disease (AD).In this parallel group, randomized, double-blind, placebo-controlled, flexible-dose trial, institutionalized subjects with AD and psychotic symptoms were randomized to aripiprazole (n = 131) or placebo (n = 125) for 10 weeks. The aripiprazole starting dose was 2 mg/day, and could be titrated to higher doses (5, 10, and 15 mg/day) based on efficacy and tolerability.No significant differences in mean change [2 x SD] from baseline between aripiprazole (mean dose approximately 9 mg/day at endpoint; range = 0.7-15.0 mg) and placebo were detected in the coprimary efficacy endpoints of Neuropsychiatric Inventory-Nursing Home Version (NPI-NH) Psychosis score (aripiprazole, -4.53 [9.23]; placebo, -4.62 [9.56]; F = 0.02, df = 1, 222, p = 0.883 [ANCOVA]) and Clinical Global Impression (CGI)-Severity score (aripiprazole, -0.57 [1.63]; placebo, -0.43 [1.65]; F = 1.67, df = 1, 220, p = 0.198 [ANCOVA]) at endpoint. However, improvements in several secondary efficacy measures (NPI-NH Total, Brief Psychiatric Rating Scale Total, CGI - improvement, Cohen-Mansfield Agitation Inventory and Cornell Depression Scale scores) indicated that aripiprazole may confer clinical benefits beyond the primary outcome measures. Treatment-emergent adverse events (AEs) were similar in both groups, except for somnolence (aripiprazole, 14%; placebo, 4%). Somnolence with aripiprazole was of mild or moderate intensity, and not associated with accidental injury. Incidence of AEs related to extrapyramidal symptoms was low with aripiprazole (5%) and placebo (4%).In nursing home residents with AD and psychosis, aripiprazole did not confer specific benefits for the treatment of psychotic symptoms; but psychological and behavioral symptoms, including agitation, anxiety, and depression, were improved with aripiprazole, with a low risk of AEs." @default.
• W2024097777 created "2016-06-24" @default.
• W2024097777 creator A5000677832 @default.
• W2024097777 creator A5029547645 @default.
• W2024097777 creator A5033585095 @default.
• W2024097777 creator A5036492697 @default.
• W2024097777 creator A5045340047 @default.
• W2024097777 creator A5048498583 @default.
• W2024097777 creator A5068998111 @default.
• W2024097777 date "2008-07-01" @default.
• W2024097777 modified "2023-10-07" @default.
• W2024097777 title "A Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole for the Treatment of Psychosis in Nursing Home Patients with Alzheimer Disease" @default.
• W2024097777 cites W1688235741 @default.
• W2024097777 cites W1867692464 @default.
• W2024097777 cites W1873238402 @default.
• W2024097777 cites W1907941906 @default.
• W2024097777 cites W1972809085 @default.
• W2024097777 cites W1985675058 @default.
• W2024097777 cites W1986179385 @default.
• W2024097777 cites W1991517279 @default.
• W2024097777 cites W1993616406 @default.
• W2024097777 cites W1993818042 @default.
• W2024097777 cites W1995618856 @default.
• W2024097777 cites W2007472466 @default.
• W2024097777 cites W2011114796 @default.
• W2024097777 cites W2013231002 @default.
• W2024097777 cites W2017402467 @default.
• W2024097777 cites W2020848554 @default.
• W2024097777 cites W2022669291 @default.
• W2024097777 cites W2023437032 @default.
• W2024097777 cites W2028020563 @default.
• W2024097777 cites W2033610699 @default.
• W2024097777 cites W2035807245 @default.
• W2024097777 cites W2042941136 @default.
• W2024097777 cites W2050721184 @default.
• W2024097777 cites W2053585074 @default.
• W2024097777 cites W2075505507 @default.
• W2024097777 cites W2076504302 @default.
• W2024097777 cites W2078919465 @default.
• W2024097777 cites W2084561734 @default.
• W2024097777 cites W2088317481 @default.
• W2024097777 cites W2091271447 @default.
• W2024097777 cites W2095124166 @default.
• W2024097777 cites W2112815097 @default.
• W2024097777 cites W2113772547 @default.
• W2024097777 cites W2117990113 @default.
• W2024097777 cites W2129678592 @default.
• W2024097777 cites W2130484447 @default.
• W2024097777 cites W2132592055 @default.
• W2024097777 cites W2132871355 @default.
• W2024097777 cites W2134080118 @default.
• W2024097777 cites W2139560403 @default.
• W2024097777 cites W2140253835 @default.
• W2024097777 cites W2142274632 @default.
• W2024097777 cites W2144373877 @default.
• W2024097777 cites W2156065126 @default.
• W2024097777 cites W2165008797 @default.
• W2024097777 cites W2168558795 @default.
• W2024097777 cites W2171151973 @default.
• W2024097777 doi "https://doi.org/10.1097/jgp.0b013e318165db77" @default.
• W2024097777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18591574" @default.
• W2024097777 hasPublicationYear "2008" @default.
• W2024097777 type Work @default.
• W2024097777 sameAs 2024097777 @default.
• W2024097777 citedByCount "95" @default.
• W2024097777 countsByYear W20240977772012 @default.
• W2024097777 countsByYear W20240977772013 @default.
• W2024097777 countsByYear W20240977772014 @default.
• W2024097777 countsByYear W20240977772015 @default.
• W2024097777 countsByYear W20240977772016 @default.
• W2024097777 countsByYear W20240977772017 @default.
• W2024097777 countsByYear W20240977772018 @default.
• W2024097777 countsByYear W20240977772019 @default.
• W2024097777 countsByYear W20240977772020 @default.
• W2024097777 countsByYear W20240977772021 @default.
• W2024097777 countsByYear W20240977772022 @default.
• W2024097777 countsByYear W20240977772023 @default.
• W2024097777 crossrefType "journal-article" @default.
• W2024097777 hasAuthorship W2024097777A5000677832 @default.
• W2024097777 hasAuthorship W2024097777A5029547645 @default.
• W2024097777 hasAuthorship W2024097777A5033585095 @default.
• W2024097777 hasAuthorship W2024097777A5036492697 @default.
• W2024097777 hasAuthorship W2024097777A5045340047 @default.
• W2024097777 hasAuthorship W2024097777A5048498583 @default.
• W2024097777 hasAuthorship W2024097777A5068998111 @default.
• W2024097777 hasConcept C118552586 @default.
• W2024097777 hasConcept C126322002 @default.
• W2024097777 hasConcept C142724271 @default.
• W2024097777 hasConcept C15744967 @default.
• W2024097777 hasConcept C168563851 @default.
• W2024097777 hasConcept C197934379 @default.
• W2024097777 hasConcept C203092338 @default.
• W2024097777 hasConcept C204787440 @default.
• W2024097777 hasConcept C27081682 @default.
• W2024097777 hasConcept C2776000289 @default.
• W2024097777 hasConcept C2776412080 @default.
• W2024097777 hasConcept C2776921671 @default.
• W2024097777 hasConcept C2778375690 @default.

• next